However, mutations in BRAF are early and not sufficient to induce melanoma: there is a high frequency of these mutations in benign nevi (including congenital, intra-dermal, and dysplastic) (Pollock et al., 2003; Tschandl et al., 2013), and it seems that additional genetic events are necessary. Here, BRAF is linked to melanoma.